Drug Manufacturers

Drug manufacturers do as the name suggests; they develop and make drugs for the healthcare industry.

Drug manufacturers create industrial-scale pharmaceutical drugs for distribution by medical practitioners, pharmacies and hospitals. To create these medicines, drug manufacturers have operations of separate units including milling, granulation, coating, tablet pressing, and others.

Examples of companies in this sector include FibroGen, Neos Therapeutics, and Diplomat Pharmacy.

Looking Forward at Impax Laboratories Inc.

Oct 16 Dylan Bernhardt

During trading today, shares of Impax Laboratories Inc. (NASDAQ:$IPXL) saw a recent bid of $21.17. In total, the stock has moved 0.81% or $0.17 from open. 49,456 shares have traded hand during the session. When ... [Read]

Hydropothecary Breaks Ground On 250,000 sq. ft. Expansion in Gatineau, Quebec

Oct 13 Dylan Bernhardt

The Hydropothecary Corporation (TSXV:$THCX) has announced today that it has broken ground on a 250,000 square foot expansion in Gatineau, Quebec. The expansion will cost $25 million and create an additional 100 full-time jobs for ... [Read]

Aurora Cannabis to Raise up to $60M

Oct 13 Jackson Chen

Aurora Cannabis to Raise up to $60M for Business Expansion Licensed producer Aurora Cannabis Inc. (TSXV:$ACB) announced on Tuesday, October 10, that it plans to raise up to $60 million under a bought deal financing. ... [Read]

Nathalie Bourque Appointed to The Hydropothecary Corporation’s Board of Directors

Oct 5 Dylan Bernhardt

Nathalie Bourque will be The Hydropothecary Corporation (TSXV:$THCX) Board of Directors, according to the company. The appointment was announced on Thursday, October 5th. The company cited Bourque’s expertise in public affairs and communications for finance ... [Read]

The Hydropothecary Corp.: What Are The Technicals?

Oct 3 Dylan Bernhardt

During trading today, shares of The Hydropothecary Corp. (TSXV:$THCX) have moved $0.06 or 2.94%, with a recent bid of $2.10. The trade volume sits at 481910. This may leave many new investors curious if now ... [Read]

Is pSivida Corp. Trending?

Oct 3 Dylan Bernhardt

According to the aggregate analysts rating, pSivida Corp. (NASDAQ:$PSDV) currently sits at an average rating of ‘Buy’. This rating is determined by analysts who look at a combination of wave theory, momentum, and volatility to ... [Read]

An Analysis of pSivida Corp.

Oct 2 Dylan Bernhardt

Recently, pSivida Corp. (NASDAQ:$PSDV) has failed to live up to its previous stock prices. The current price stands -1.41% below the 20 day average. While the stock did recover partially over the 50 day moving ... [Read]

pSivida Announces Development of Sustained Release Glaucoma Drug with a Partner Global Pharmaceuticals Company

Sep 29 Dylan Bernhardt

pSivida Corp (NASDAQ:$PSDV) has announced that it has signed an agreement with a major global pharmaceutical company to develop two new glaucoma drugs using their proprietary sustained release technology. The company is a leading developer ... [Read]

pSivida Corp.: What the Indicators Tell Us

Sep 28 Dylan Bernhardt

Recently, traders have noticed that pSivida Corp. (NASDAQ:$PSDV) stock has seen its Percentage Price Oscillator Histogram level just under zero. This could indicate it may be time to sell. Another tool for forecasting a stock ... [Read]

Cantor Fitzgerald Restates Impax Laboratories’ ‘Buy’ Rating

Sep 26 Dylan Bernhardt

On Monday, research analysts Cantor Fitzgerald restated a ‘Buy’ rating for Impax Laboratories, Inc. (NASDAQ:$IPXL). Cantor Fitzgerald also set a price target of $25.00, indicating a potential 8.70% from the stock’s current position. The rating ... [Read]